Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities.
J Am Chem Soc. 2010 Jan 20;132(2):656-66. doi: 10.1021/ja907716f.
J Am Chem Soc. 2010.
PMID: 20028024